← Back to Search

Radiation Therapy

MR-Guided Prostate SBRT for Prostate Cancer (PRAGMA Trial)

N/A
Waitlist Available
Led By Josephine Kang, M.D.,Ph.D.
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3-6months and at 9-12 months.
Awards & highlights

PRAGMA Trial Summary

This trial finds that MRI-guided prostate SBRT is safe for patients with metastatic prostate cancer, with similar quality of life outcomes to those without metastatic prostate cancer.

Eligible Conditions
  • Hormone-Refractory Prostate Cancer

PRAGMA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3-6months and at 9-12 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3-6months and at 9-12 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Number of Subjects With Adverse Events Will be Collected
Secondary outcome measures
Change in Quality of Life Questionnaires Will be Assessed.
Change in The International Prostate Symptom Score (I-PSS) Will be Assessed.

PRAGMA Trial Design

1Treatment groups
Experimental Treatment
Group I: MR-Guided Prostate SBRTExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MR-Guided Prostate SBRT
2020
N/A
~30

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,054 Previous Clinical Trials
1,316,564 Total Patients Enrolled
49 Trials studying Prostate Cancer
35,639 Patients Enrolled for Prostate Cancer
Josephine Kang, M.D.,Ph.D.Principal InvestigatorWeill Medical College of Cornell University
1 Previous Clinical Trials
50 Total Patients Enrolled
1 Trials studying Prostate Cancer
50 Patients Enrolled for Prostate Cancer
Ariel Marciscano, M.D.Principal InvestigatorWeill Medical College of Cornell University
1 Previous Clinical Trials
50 Total Patients Enrolled
1 Trials studying Prostate Cancer
50 Patients Enrolled for Prostate Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical experiment require additional participants?

"Affirmative. Clinicaltrials.gov confirms that this research is actively searching for participants and has been since January 27th 2020. 20 individuals are required from a single trial site, with the most recent update on April 10th 2022."

Answered by AI

How many participants will be included in this research endeavor?

"Affirmative, the data from clinicaltrials.gov reveals that this medical trial is in the process of enrolling participants. This study was first shared on January 27th 2020 and last updated April 10th 2022; with a target of 20 patients at one site."

Answered by AI

Are elderly individuals aged 75 and over able to partake in this medical experiment?

"As dictated by the protocols of this medical trial, prospective participants must be aged 18 or older but no more than 90."

Answered by AI

May I be considered for enrollment in this scientific inquiry?

"Researchers are recruiting up to 20 individuals with prostate cancer, aged 18-90. Notably, applicants must demonstrate a biopsy diagnosis of adenocarcinoma and fulfill the minimum age requirement."

Answered by AI

Has this remedy received authorization from the FDA?

"This treatment has been seen to possess some clinical efficacy and rudimentary safety data, so it was given a rating of 1 on our team's scale."

Answered by AI
~4 spots leftby Apr 2025